(Q40820981)

24 September 2017

title

Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374. (English)

1 reference

24 September 2017

Sharmeen L

1

1 reference

24 September 2017

McQuade T

2

1 reference

24 September 2017

Heldsinger A

3

1 reference

24 September 2017

Gogliotti R

4

1 reference

24 September 2017

Domagala J

5

1 reference

24 September 2017

Gracheck S

6

1 reference

24 September 2017

publication date

1 February 2001

1 reference

24 September 2017

1 reference

24 September 2017

volume

49

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

101-114

1 reference

Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

1 reference

7 January 2021

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

2,2'-Dithiobisbenzamides derived from alpha-, beta- and gamma-amino acids possessing anti-HIV activities: synthesis and structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900143-1

7 January 2021

10.1016/S0166-3542(00)00143-1

Identifiers

DOI

1 reference

24 September 2017

1 reference